Publications

Case Reports
Journal Article Research Support, Non-U.S. Gov't
Ppublish 289 citations
Electronic publication date
January 1, 1995

View on Pubmed.gov 7805037 View on doi.org

The novel activation of ABL by fusion to an ets-related gene, TEL.

Search for publications in this journal Cancer Res - 55(1):34-8

Abstract

In human leukemia, activation of the ABL proto-oncogene locus on chromosome 9 most commonly occurs as a result of its fusion to the BCR locus on chromosome 22. The resulting chimeric protein displays an elevated tyrosine kinase activity. We have identified a novel activation of ABL which involves a gene located on chromosome 12, designated TEL. Like BCR, TEL is fused in-frame with ABL and produces a fusion protein with an elevated tyrosine kinase activity when assayed in an immune complex. The amino-terminal sequences of TEL encode a helix-loop-helix motif which may mediate dimerization.

References

No references provided.

Cited by 289 citations (total)

Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1.

Electronic publication date September 1, 1996

Search for publications in this journal Mol Cell Biol

P Oettgen [...] T A Libermann et al.

We have cloned the gene for a novel Ets-related transcription factor, new Ets-related factor (NERF), from human spleen, fetal liver,...

Journal Article Research Support, U.S. Gov't, P.H.S.

A chimeric receptor/oncogene that can be regulated by a ligand in vitro and in vivo.

Electronic publication date October 6, 1997

Search for publications in this journal J Clin Invest

K Okuda [...] J D Griffin et al.

The BCR/ABL oncogene encodes an activated tyrosine kinase that causes human chronic myelogenous leukemia. The mechanism of transformation, however, is...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances